id	sid	tid	token	lemma	pos
work_26nhqvmztzhljeufl75hmtirqi	1	1	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	1	2	Doorstep	Doorstep	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	3	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	1	4	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	1	5	Temple	Temple	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	6	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	1	7	Wisdom	Wisdom	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	8	THE	the	DT
work_26nhqvmztzhljeufl75hmtirqi	1	9	BOTTOM	bottom	JJ
work_26nhqvmztzhljeufl75hmtirqi	1	10	LINE	line	NN
work_26nhqvmztzhljeufl75hmtirqi	1	11	From	from	IN
work_26nhqvmztzhljeufl75hmtirqi	1	12	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	1	13	Baltim	Baltim	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	14	Financial	Financial	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	15	d	d	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	16	Correspon	Correspon	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	17	Depar	Depar	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	18	Orlea	Orlea	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	19	gbvog	gbvog	NN
work_26nhqvmztzhljeufl75hmtirqi	1	20	Received	receive	VBD
work_26nhqvmztzhljeufl75hmtirqi	1	21	J	J	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	22	�	�	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	23	2011	2011	CD
work_26nhqvmztzhljeufl75hmtirqi	1	24	Am	Am	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	25	1083	1083	CD
work_26nhqvmztzhljeufl75hmtirqi	1	26	-	-	SYM
work_26nhqvmztzhljeufl75hmtirqi	1	27	8791	8791	CD
work_26nhqvmztzhljeufl75hmtirqi	1	28	doi:10.101	doi:10.101	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	29	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	1	30	Doorstep	Doorstep	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	31	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	1	32	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	1	33	Temple	Temple	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	34	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	1	35	Wisdom	Wisdom	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	36	Georgia	Georgia	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	37	Vogelsang	Vogelsang	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	38	‘	'	``
work_26nhqvmztzhljeufl75hmtirqi	1	39	‘	'	``
work_26nhqvmztzhljeufl75hmtirqi	1	40	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	1	41	doorstep	doorstep	NN
work_26nhqvmztzhljeufl75hmtirqi	1	42	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	1	43	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	1	44	temple	temple	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	45	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	1	46	wisdom	wisdom	NN
work_26nhqvmztzhljeufl75hmtirqi	1	47	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	1	48	knowl-	knowl-	JJ
work_26nhqvmztzhljeufl75hmtirqi	1	49	edge	edge	NN
work_26nhqvmztzhljeufl75hmtirqi	1	50	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	1	51	our	-PRON-	PRP$
work_26nhqvmztzhljeufl75hmtirqi	1	52	own	own	JJ
work_26nhqvmztzhljeufl75hmtirqi	1	53	ignorance	ignorance	NN
work_26nhqvmztzhljeufl75hmtirqi	1	54	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	1	55	’	'	''
work_26nhqvmztzhljeufl75hmtirqi	1	56	’	'	''
work_26nhqvmztzhljeufl75hmtirqi	1	57	Benjamin	Benjamin	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	58	Franklin	Franklin	NNP
work_26nhqvmztzhljeufl75hmtirqi	1	59	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	2	1	In	in	IN
work_26nhqvmztzhljeufl75hmtirqi	2	2	this	this	DT
work_26nhqvmztzhljeufl75hmtirqi	2	3	issue	issue	NN
work_26nhqvmztzhljeufl75hmtirqi	2	4	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	2	5	Pidala	Pidala	NNP
work_26nhqvmztzhljeufl75hmtirqi	2	6	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	2	7	colleagues	colleague	NNS
work_26nhqvmztzhljeufl75hmtirqi	2	8	report	report	VBP
work_26nhqvmztzhljeufl75hmtirqi	2	9	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	2	10	ap-	ap-	NNP
work_26nhqvmztzhljeufl75hmtirqi	2	11	palling	palling	NN
work_26nhqvmztzhljeufl75hmtirqi	2	12	state	state	NN
work_26nhqvmztzhljeufl75hmtirqi	2	13	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	2	14	ignorance	ignorance	NN
work_26nhqvmztzhljeufl75hmtirqi	2	15	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	2	16	confusion	confusion	NN
work_26nhqvmztzhljeufl75hmtirqi	2	17	regarding	regard	VBG
work_26nhqvmztzhljeufl75hmtirqi	2	18	withdraw	withdraw	NN
work_26nhqvmztzhljeufl75hmtirqi	2	19	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	2	20	immunosuppression	immunosuppression	NN
work_26nhqvmztzhljeufl75hmtirqi	2	21	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	2	22	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	2	23	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	2	24	after	after	IN
work_26nhqvmztzhljeufl75hmtirqi	2	25	allogeneic	allogeneic	IN
work_26nhqvmztzhljeufl75hmtirqi	2	26	hematopoietic	hematopoietic	JJ
work_26nhqvmztzhljeufl75hmtirqi	2	27	stem	stem	NN
work_26nhqvmztzhljeufl75hmtirqi	2	28	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	2	29	transplantation	transplantation	NN
work_26nhqvmztzhljeufl75hmtirqi	2	30	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	2	31	allo	allo	NNP
work_26nhqvmztzhljeufl75hmtirqi	2	32	HCT	HCT	NNP
work_26nhqvmztzhljeufl75hmtirqi	2	33	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	2	34	[	[	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	2	35	1	1	CD
work_26nhqvmztzhljeufl75hmtirqi	2	36	]	]	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	2	37	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	3	1	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	3	2	authors	author	NNS
work_26nhqvmztzhljeufl75hmtirqi	3	3	document	document	NN
work_26nhqvmztzhljeufl75hmtirqi	3	4	marked	mark	VBD
work_26nhqvmztzhljeufl75hmtirqi	3	5	variation	variation	NN
work_26nhqvmztzhljeufl75hmtirqi	3	6	practice	practice	NN
work_26nhqvmztzhljeufl75hmtirqi	3	7	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	3	8	even	even	RB
work_26nhqvmztzhljeufl75hmtirqi	3	9	within	within	IN
work_26nhqvmztzhljeufl75hmtirqi	3	10	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	3	11	same	same	JJ
work_26nhqvmztzhljeufl75hmtirqi	3	12	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	3	13	group	group	NN
work_26nhqvmztzhljeufl75hmtirqi	3	14	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	3	15	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	3	16	high	high	JJ
work_26nhqvmztzhljeufl75hmtirqi	3	17	esti-	esti-	NN
work_26nhqvmztzhljeufl75hmtirqi	3	18	mates	mate	NNS
work_26nhqvmztzhljeufl75hmtirqi	3	19	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	3	20	graft	graft	NN
work_26nhqvmztzhljeufl75hmtirqi	3	21	-	-	HYPH
work_26nhqvmztzhljeufl75hmtirqi	3	22	vs	vs	IN
work_26nhqvmztzhljeufl75hmtirqi	3	23	-	-	HYPH
work_26nhqvmztzhljeufl75hmtirqi	3	24	host	host	NN
work_26nhqvmztzhljeufl75hmtirqi	3	25	disease	disease	NN
work_26nhqvmztzhljeufl75hmtirqi	3	26	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	3	27	GVHD	GVHD	NNP
work_26nhqvmztzhljeufl75hmtirqi	3	28	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	3	29	emerging	emerge	VBG
work_26nhqvmztzhljeufl75hmtirqi	3	30	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	3	31	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	3	32	setting	setting	NN
work_26nhqvmztzhljeufl75hmtirqi	3	33	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	3	34	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	3	35	taper	taper	NN
work_26nhqvmztzhljeufl75hmtirqi	3	36	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	3	37	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	3	38	limited	limited	JJ
work_26nhqvmztzhljeufl75hmtirqi	3	39	confidence	confidence	NN
work_26nhqvmztzhljeufl75hmtirqi	3	40	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	3	41	trans-	trans-	NN
work_26nhqvmztzhljeufl75hmtirqi	3	42	plant	plant	NN
work_26nhqvmztzhljeufl75hmtirqi	3	43	physicians	physician	NNS
work_26nhqvmztzhljeufl75hmtirqi	3	44	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	3	45	their	-PRON-	PRP$
work_26nhqvmztzhljeufl75hmtirqi	3	46	therapeutic	therapeutic	JJ
work_26nhqvmztzhljeufl75hmtirqi	3	47	decisions	decision	NNS
work_26nhqvmztzhljeufl75hmtirqi	3	48	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	4	1	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	4	2	egress	egress	NN
work_26nhqvmztzhljeufl75hmtirqi	4	3	from	from	IN
work_26nhqvmztzhljeufl75hmtirqi	4	4	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	4	5	temple	temple	NN
work_26nhqvmztzhljeufl75hmtirqi	4	6	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	4	7	stem	stem	NN
work_26nhqvmztzhljeufl75hmtirqi	4	8	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	4	9	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	4	10	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	4	11	indeed	indeed	RB
work_26nhqvmztzhljeufl75hmtirqi	4	12	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	4	13	jumbled	jumble	VBN
work_26nhqvmztzhljeufl75hmtirqi	4	14	muddle	muddle	NN
work_26nhqvmztzhljeufl75hmtirqi	4	15	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	5	1	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	5	2	investigators	investigator	NNS
work_26nhqvmztzhljeufl75hmtirqi	5	3	surveyed	survey	VBD
work_26nhqvmztzhljeufl75hmtirqi	5	4	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	5	5	American	American	NNP
work_26nhqvmztzhljeufl75hmtirqi	5	6	Society	Society	NNP
work_26nhqvmztzhljeufl75hmtirqi	5	7	Blood	Blood	NNP
work_26nhqvmztzhljeufl75hmtirqi	5	8	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	5	9	Marrow	Marrow	NNP
work_26nhqvmztzhljeufl75hmtirqi	5	10	Transplantation	Transplantation	NNP
work_26nhqvmztzhljeufl75hmtirqi	5	11	members	member	NNS
work_26nhqvmztzhljeufl75hmtirqi	5	12	using	use	VBG
work_26nhqvmztzhljeufl75hmtirqi	5	13	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	5	14	series	series	NN
work_26nhqvmztzhljeufl75hmtirqi	5	15	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	5	16	clinical	clinical	JJ
work_26nhqvmztzhljeufl75hmtirqi	5	17	vignettes	vignette	NNS
work_26nhqvmztzhljeufl75hmtirqi	5	18	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	5	19	explore	explore	VB
work_26nhqvmztzhljeufl75hmtirqi	5	20	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	5	21	management	management	NN
work_26nhqvmztzhljeufl75hmtirqi	5	22	after	after	IN
work_26nhqvmztzhljeufl75hmtirqi	5	23	allo	allo	NNP
work_26nhqvmztzhljeufl75hmtirqi	5	24	HCT	HCT	NNP
work_26nhqvmztzhljeufl75hmtirqi	5	25	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	6	1	Unfortunately	unfortunately	RB
work_26nhqvmztzhljeufl75hmtirqi	6	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	6	3	only	only	RB
work_26nhqvmztzhljeufl75hmtirqi	6	4	21	21	CD
work_26nhqvmztzhljeufl75hmtirqi	6	5	%	%	NN
work_26nhqvmztzhljeufl75hmtirqi	6	6	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	6	7	physician	physician	NN
work_26nhqvmztzhljeufl75hmtirqi	6	8	members	member	NNS
work_26nhqvmztzhljeufl75hmtirqi	6	9	participated	participate	VBD
work_26nhqvmztzhljeufl75hmtirqi	6	10	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	6	11	which	which	WDT
work_26nhqvmztzhljeufl75hmtirqi	6	12	does	do	VBZ
work_26nhqvmztzhljeufl75hmtirqi	6	13	add	add	VB
work_26nhqvmztzhljeufl75hmtirqi	6	14	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	6	15	note	note	NN
work_26nhqvmztzhljeufl75hmtirqi	6	16	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	6	17	con-	con-	NN
work_26nhqvmztzhljeufl75hmtirqi	6	18	cern	cern	NN
work_26nhqvmztzhljeufl75hmtirqi	6	19	over	over	IN
work_26nhqvmztzhljeufl75hmtirqi	6	20	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	6	21	validity	validity	NN
work_26nhqvmztzhljeufl75hmtirqi	6	22	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	6	23	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	6	24	results	result	NNS
work_26nhqvmztzhljeufl75hmtirqi	6	25	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	7	1	Even	even	RB
work_26nhqvmztzhljeufl75hmtirqi	7	2	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	7	3	this	this	DT
work_26nhqvmztzhljeufl75hmtirqi	7	4	ca-	ca-	XX
work_26nhqvmztzhljeufl75hmtirqi	7	5	veat	veat	NN
work_26nhqvmztzhljeufl75hmtirqi	7	6	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	7	7	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	7	8	results	result	NNS
work_26nhqvmztzhljeufl75hmtirqi	7	9	are	be	VBP
work_26nhqvmztzhljeufl75hmtirqi	7	10	alarming	alarming	JJ
work_26nhqvmztzhljeufl75hmtirqi	7	11	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	8	1	For	for	IN
work_26nhqvmztzhljeufl75hmtirqi	8	2	example	example	NN
work_26nhqvmztzhljeufl75hmtirqi	8	3	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	8	4	25	25	CD
work_26nhqvmztzhljeufl75hmtirqi	8	5	%	%	NN
work_26nhqvmztzhljeufl75hmtirqi	8	6	indicated	indicate	VBD
work_26nhqvmztzhljeufl75hmtirqi	8	7	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	8	8	they	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	8	9	had	have	VBD
work_26nhqvmztzhljeufl75hmtirqi	8	10	no	no	DT
work_26nhqvmztzhljeufl75hmtirqi	8	11	consistent	consistent	JJ
work_26nhqvmztzhljeufl75hmtirqi	8	12	strategy	strategy	NN
work_26nhqvmztzhljeufl75hmtirqi	8	13	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	8	14	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	8	15	ta-	ta-	RB
work_26nhqvmztzhljeufl75hmtirqi	8	16	pering	pering	NN
work_26nhqvmztzhljeufl75hmtirqi	8	17	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	8	18	half	half	NN
work_26nhqvmztzhljeufl75hmtirqi	8	19	said	say	VBD
work_26nhqvmztzhljeufl75hmtirqi	8	20	they	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	8	21	had	have	VBD
work_26nhqvmztzhljeufl75hmtirqi	8	22	no	no	DT
work_26nhqvmztzhljeufl75hmtirqi	8	23	institutional	institutional	JJ
work_26nhqvmztzhljeufl75hmtirqi	8	24	guidelines	guideline	NNS
work_26nhqvmztzhljeufl75hmtirqi	8	25	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	8	26	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	8	27	tapering	taper	VBG
work_26nhqvmztzhljeufl75hmtirqi	8	28	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	9	1	There	there	EX
work_26nhqvmztzhljeufl75hmtirqi	9	2	was	be	VBD
work_26nhqvmztzhljeufl75hmtirqi	9	3	marked	mark	VBN
work_26nhqvmztzhljeufl75hmtirqi	9	4	variation	variation	NN
work_26nhqvmztzhljeufl75hmtirqi	9	5	among	among	IN
work_26nhqvmztzhljeufl75hmtirqi	9	6	re-	re-	JJ
work_26nhqvmztzhljeufl75hmtirqi	9	7	spondents	spondent	NNS
work_26nhqvmztzhljeufl75hmtirqi	9	8	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	9	9	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	9	10	taper	taper	NN
work_26nhqvmztzhljeufl75hmtirqi	9	11	schedule	schedule	NN
work_26nhqvmztzhljeufl75hmtirqi	9	12	both	both	CC
work_26nhqvmztzhljeufl75hmtirqi	9	13	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	9	14	terms	term	NNS
work_26nhqvmztzhljeufl75hmtirqi	9	15	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	9	16	timing	timing	NN
work_26nhqvmztzhljeufl75hmtirqi	9	17	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	9	18	drug	drug	NN
work_26nhqvmztzhljeufl75hmtirqi	9	19	dose	dose	VBD
work_26nhqvmztzhljeufl75hmtirqi	9	20	reduction	reduction	NN
work_26nhqvmztzhljeufl75hmtirqi	9	21	even	even	RB
work_26nhqvmztzhljeufl75hmtirqi	9	22	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	9	23	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	9	24	base	base	NN
work_26nhqvmztzhljeufl75hmtirqi	9	25	case	case	NN
work_26nhqvmztzhljeufl75hmtirqi	9	26	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	9	27	an	an	DT
work_26nhqvmztzhljeufl75hmtirqi	9	28	un-	un-	JJ
work_26nhqvmztzhljeufl75hmtirqi	9	29	complicated	complicated	JJ
work_26nhqvmztzhljeufl75hmtirqi	9	30	HLA	HLA	NNP
work_26nhqvmztzhljeufl75hmtirqi	9	31	identical	identical	JJ
work_26nhqvmztzhljeufl75hmtirqi	9	32	sibling	sibling	NN
work_26nhqvmztzhljeufl75hmtirqi	9	33	HCT	hct	NN
work_26nhqvmztzhljeufl75hmtirqi	9	34	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	10	1	As	as	IN
work_26nhqvmztzhljeufl75hmtirqi	10	2	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	10	3	inves-	inves-	NN
work_26nhqvmztzhljeufl75hmtirqi	10	4	tigators	tigator	NNS
work_26nhqvmztzhljeufl75hmtirqi	10	5	added	add	VBD
work_26nhqvmztzhljeufl75hmtirqi	10	6	complexity	complexity	NN
work_26nhqvmztzhljeufl75hmtirqi	10	7	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	10	8	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	10	9	base	base	NN
work_26nhqvmztzhljeufl75hmtirqi	10	10	case	case	NN
work_26nhqvmztzhljeufl75hmtirqi	10	11	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	10	12	use	use	NN
work_26nhqvmztzhljeufl75hmtirqi	10	13	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	10	14	peripheral	peripheral	JJ
work_26nhqvmztzhljeufl75hmtirqi	10	15	blood	blood	NN
work_26nhqvmztzhljeufl75hmtirqi	10	16	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	10	17	unrelated	unrelated	JJ
work_26nhqvmztzhljeufl75hmtirqi	10	18	donor	donor	NN
work_26nhqvmztzhljeufl75hmtirqi	10	19	graft	graft	NN
work_26nhqvmztzhljeufl75hmtirqi	10	20	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	10	21	relapse	relapse	VB
work_26nhqvmztzhljeufl75hmtirqi	10	22	post	post	NN
work_26nhqvmztzhljeufl75hmtirqi	10	23	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	10	24	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	10	25	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	10	26	so	so	RB
work_26nhqvmztzhljeufl75hmtirqi	10	27	forth	forth	RB
work_26nhqvmztzhljeufl75hmtirqi	10	28	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	10	29	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	10	30	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	10	31	variations	variation	NNS
work_26nhqvmztzhljeufl75hmtirqi	10	32	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	10	33	uncertainty	uncertainty	NN
work_26nhqvmztzhljeufl75hmtirqi	10	34	increased	increase	VBD
work_26nhqvmztzhljeufl75hmtirqi	10	35	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	11	1	Moreover	moreover	RB
work_26nhqvmztzhljeufl75hmtirqi	11	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	11	3	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	11	4	respondents	respondent	NNS
work_26nhqvmztzhljeufl75hmtirqi	11	5	estimated	estimate	VBD
work_26nhqvmztzhljeufl75hmtirqi	11	6	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	11	7	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	11	8	IS	IS	NNP
work_26nhqvmztzhljeufl75hmtirqi	11	9	approach	approach	NN
work_26nhqvmztzhljeufl75hmtirqi	11	10	they	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	11	11	used	use	VBD
work_26nhqvmztzhljeufl75hmtirqi	11	12	was	be	VBD
work_26nhqvmztzhljeufl75hmtirqi	11	13	likely	likely	JJ
work_26nhqvmztzhljeufl75hmtirqi	11	14	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	11	15	result	result	VB
work_26nhqvmztzhljeufl75hmtirqi	11	16	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	11	17	recur-	recur-	JJ
work_26nhqvmztzhljeufl75hmtirqi	11	18	rent	rent	NN
work_26nhqvmztzhljeufl75hmtirqi	11	19	acute	acute	JJ
work_26nhqvmztzhljeufl75hmtirqi	11	20	GVHD	GVHD	NNP
work_26nhqvmztzhljeufl75hmtirqi	11	21	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	11	22	aGVHD	agvhd	NN
work_26nhqvmztzhljeufl75hmtirqi	11	23	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	11	24	and/or	and/or	CC
work_26nhqvmztzhljeufl75hmtirqi	11	25	chronic	chronic	JJ
work_26nhqvmztzhljeufl75hmtirqi	11	26	GVHD	gvhd	NN
work_26nhqvmztzhljeufl75hmtirqi	11	27	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	11	28	cGVHD	cgvhd	NN
work_26nhqvmztzhljeufl75hmtirqi	11	29	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	11	30	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	11	31	many	many	JJ
work_26nhqvmztzhljeufl75hmtirqi	11	32	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	11	33	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	12	1	A	a	DT
work_26nhqvmztzhljeufl75hmtirqi	12	2	total	total	NN
work_26nhqvmztzhljeufl75hmtirqi	12	3	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	12	4	41	41	CD
work_26nhqvmztzhljeufl75hmtirqi	12	5	%	%	NN
work_26nhqvmztzhljeufl75hmtirqi	12	6	reported	report	VBD
work_26nhqvmztzhljeufl75hmtirqi	12	7	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	12	8	their	-PRON-	PRP$
work_26nhqvmztzhljeufl75hmtirqi	12	9	current	current	JJ
work_26nhqvmztzhljeufl75hmtirqi	12	10	strategy	strategy	NN
work_26nhqvmztzhljeufl75hmtirqi	12	11	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	12	12	IS	IS	NNP
work_26nhqvmztzhljeufl75hmtirqi	12	13	management	management	NN
work_26nhqvmztzhljeufl75hmtirqi	12	14	post-	post-	NNP
work_26nhqvmztzhljeufl75hmtirqi	12	15	HCT	HCT	NNP
work_26nhqvmztzhljeufl75hmtirqi	12	16	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	12	17	not	not	RB
work_26nhqvmztzhljeufl75hmtirqi	12	18	adequate	adequate	JJ
work_26nhqvmztzhljeufl75hmtirqi	12	19	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	12	20	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	12	21	26	26	CD
work_26nhqvmztzhljeufl75hmtirqi	12	22	%	%	NN
work_26nhqvmztzhljeufl75hmtirqi	12	23	admitted	admit	VBD
work_26nhqvmztzhljeufl75hmtirqi	12	24	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	12	25	they	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	12	26	are	be	VBP
work_26nhqvmztzhljeufl75hmtirqi	12	27	either	either	CC
work_26nhqvmztzhljeufl75hmtirqi	12	28	uncomfortable	uncomfortable	JJ
work_26nhqvmztzhljeufl75hmtirqi	12	29	or	or	CC
work_26nhqvmztzhljeufl75hmtirqi	12	30	very	very	RB
work_26nhqvmztzhljeufl75hmtirqi	12	31	uncomfortable	uncomfortable	JJ
work_26nhqvmztzhljeufl75hmtirqi	12	32	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	12	33	making	make	VBG
work_26nhqvmztzhljeufl75hmtirqi	12	34	decisions	decision	NNS
work_26nhqvmztzhljeufl75hmtirqi	12	35	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	12	36	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	12	37	management	management	NN
work_26nhqvmztzhljeufl75hmtirqi	12	38	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	12	39	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	12	40	post	post	JJ
work_26nhqvmztzhljeufl75hmtirqi	12	41	-	-	JJ
work_26nhqvmztzhljeufl75hmtirqi	12	42	HCT	hct	JJ
work_26nhqvmztzhljeufl75hmtirqi	12	43	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	13	1	Department	Department	NNP
work_26nhqvmztzhljeufl75hmtirqi	13	2	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	13	3	Oncology	Oncology	NNP
work_26nhqvmztzhljeufl75hmtirqi	13	4	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	13	5	Johns	Johns	NNP
work_26nhqvmztzhljeufl75hmtirqi	13	6	Hopkins	Hopkins	NNP
work_26nhqvmztzhljeufl75hmtirqi	13	7	Hospital	Hospital	NNP
work_26nhqvmztzhljeufl75hmtirqi	13	8	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	13	9	ore	ore	NN
work_26nhqvmztzhljeufl75hmtirqi	13	10	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	13	11	Maryland	Maryland	NNP
work_26nhqvmztzhljeufl75hmtirqi	13	12	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	14	1	isclosure	isclosure	NN
work_26nhqvmztzhljeufl75hmtirqi	14	2	:	:	:
work_26nhqvmztzhljeufl75hmtirqi	14	3	See	see	VB
work_26nhqvmztzhljeufl75hmtirqi	14	4	Acknowledgment	Acknowledgment	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	5	on	on	IN
work_26nhqvmztzhljeufl75hmtirqi	14	6	page	page	NN
work_26nhqvmztzhljeufl75hmtirqi	14	7	1418	1418	CD
work_26nhqvmztzhljeufl75hmtirqi	14	8	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	14	9	dence	dence	NN
work_26nhqvmztzhljeufl75hmtirqi	14	10	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	14	11	reprint	reprint	NN
work_26nhqvmztzhljeufl75hmtirqi	14	12	requests	request	NNS
work_26nhqvmztzhljeufl75hmtirqi	14	13	:	:	:
work_26nhqvmztzhljeufl75hmtirqi	14	14	Georgia	Georgia	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	15	Vogelsang	Vogelsang	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	16	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	14	17	MD	MD	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	18	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	14	19	tment	tment	NN
work_26nhqvmztzhljeufl75hmtirqi	14	20	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	14	21	Oncology	Oncology	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	22	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	14	23	Johns	Johns	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	24	Hopkins	Hopkins	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	25	Hospital	Hospital	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	26	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	14	27	1650	1650	CD
work_26nhqvmztzhljeufl75hmtirqi	14	28	ns	ns	IN
work_26nhqvmztzhljeufl75hmtirqi	14	29	Street	Street	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	30	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	14	31	Room	Room	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	32	2M89	2m89	CD
work_26nhqvmztzhljeufl75hmtirqi	14	33	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	14	34	Baltimore	Baltimore	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	35	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	14	36	MD	MD	NNP
work_26nhqvmztzhljeufl75hmtirqi	14	37	21231	21231	CD
work_26nhqvmztzhljeufl75hmtirqi	14	38	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	14	39	e	e	NN
work_26nhqvmztzhljeufl75hmtirqi	14	40	-	-	NN
work_26nhqvmztzhljeufl75hmtirqi	14	41	mail	mail	NN
work_26nhqvmztzhljeufl75hmtirqi	14	42	:	:	:
work_26nhqvmztzhljeufl75hmtirqi	14	43	elsang@gmail.com	elsang@gmail.com	ADD
work_26nhqvmztzhljeufl75hmtirqi	14	44	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	14	45	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	15	1	uly	uly	NNP
work_26nhqvmztzhljeufl75hmtirqi	15	2	28	28	CD
work_26nhqvmztzhljeufl75hmtirqi	15	3	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	15	4	2011	2011	CD
work_26nhqvmztzhljeufl75hmtirqi	15	5	;	;	:
work_26nhqvmztzhljeufl75hmtirqi	15	6	accepted	accept	VBN
work_26nhqvmztzhljeufl75hmtirqi	15	7	August	August	NNP
work_26nhqvmztzhljeufl75hmtirqi	15	8	4	4	CD
work_26nhqvmztzhljeufl75hmtirqi	15	9	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	15	10	2011	2011	CD
work_26nhqvmztzhljeufl75hmtirqi	15	11	erican	erican	JJ
work_26nhqvmztzhljeufl75hmtirqi	15	12	Society	Society	NNP
work_26nhqvmztzhljeufl75hmtirqi	15	13	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	15	14	Blood	Blood	NNP
work_26nhqvmztzhljeufl75hmtirqi	15	15	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	15	16	Marrow	Marrow	NNP
work_26nhqvmztzhljeufl75hmtirqi	15	17	Transplantation	Transplantation	NNP
work_26nhqvmztzhljeufl75hmtirqi	15	18	/$36.00	/$36.00	NFP
work_26nhqvmztzhljeufl75hmtirqi	15	19	6	6	CD
work_26nhqvmztzhljeufl75hmtirqi	15	20	/	/	SYM
work_26nhqvmztzhljeufl75hmtirqi	15	21	j.bbmt.2011.08.004	j.bbmt.2011.08.004	CD
work_26nhqvmztzhljeufl75hmtirqi	15	22	What	what	WP
work_26nhqvmztzhljeufl75hmtirqi	15	23	happened	happen	VBD
work_26nhqvmztzhljeufl75hmtirqi	15	24	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	15	25	create	create	VB
work_26nhqvmztzhljeufl75hmtirqi	15	26	this	this	DT
work_26nhqvmztzhljeufl75hmtirqi	15	27	muddle	muddle	NN
work_26nhqvmztzhljeufl75hmtirqi	15	28	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	15	29	uncer-	uncer-	JJ
work_26nhqvmztzhljeufl75hmtirqi	15	30	tainty	tainty	NN
work_26nhqvmztzhljeufl75hmtirqi	15	31	?	?	.
work_26nhqvmztzhljeufl75hmtirqi	16	1	There	there	EX
work_26nhqvmztzhljeufl75hmtirqi	16	2	are	be	VBP
work_26nhqvmztzhljeufl75hmtirqi	16	3	multiple	multiple	JJ
work_26nhqvmztzhljeufl75hmtirqi	16	4	factors	factor	NNS
work_26nhqvmztzhljeufl75hmtirqi	16	5	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	17	1	First	first	RB
work_26nhqvmztzhljeufl75hmtirqi	17	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	17	3	transplanta-	transplanta-	JJ
work_26nhqvmztzhljeufl75hmtirqi	17	4	tion	tion	NN
work_26nhqvmztzhljeufl75hmtirqi	17	5	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	17	6	become	become	VBN
work_26nhqvmztzhljeufl75hmtirqi	17	7	more	more	RBR
work_26nhqvmztzhljeufl75hmtirqi	17	8	diverse	diverse	JJ
work_26nhqvmztzhljeufl75hmtirqi	17	9	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	18	1	It	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	18	2	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	18	3	gone	go	VBN
work_26nhqvmztzhljeufl75hmtirqi	18	4	from	from	IN
work_26nhqvmztzhljeufl75hmtirqi	18	5	2	2	CD
work_26nhqvmztzhljeufl75hmtirqi	18	6	basic	basic	JJ
work_26nhqvmztzhljeufl75hmtirqi	18	7	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	18	8	types	type	NNS
work_26nhqvmztzhljeufl75hmtirqi	18	9	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	18	10	autologous	autologous	JJ
work_26nhqvmztzhljeufl75hmtirqi	18	11	or	or	CC
work_26nhqvmztzhljeufl75hmtirqi	18	12	identical	identical	JJ
work_26nhqvmztzhljeufl75hmtirqi	18	13	sibling	sibling	NN
work_26nhqvmztzhljeufl75hmtirqi	18	14	allogeneic	allogeneic	NNS
work_26nhqvmztzhljeufl75hmtirqi	18	15	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	18	16	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	18	17	almost	almost	RB
work_26nhqvmztzhljeufl75hmtirqi	18	18	endless	endless	JJ
work_26nhqvmztzhljeufl75hmtirqi	18	19	combinations	combination	NNS
work_26nhqvmztzhljeufl75hmtirqi	18	20	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	18	21	donor	donor	NN
work_26nhqvmztzhljeufl75hmtirqi	18	22	types	type	NNS
work_26nhqvmztzhljeufl75hmtirqi	18	23	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	18	24	stem	stem	VB
work_26nhqvmztzhljeufl75hmtirqi	18	25	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	18	26	sources	source	NNS
work_26nhqvmztzhljeufl75hmtirqi	18	27	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	19	1	Results	result	NNS
work_26nhqvmztzhljeufl75hmtirqi	19	2	from	from	IN
work_26nhqvmztzhljeufl75hmtirqi	19	3	clinical	clinical	JJ
work_26nhqvmztzhljeufl75hmtirqi	19	4	trials	trial	NNS
work_26nhqvmztzhljeufl75hmtirqi	19	5	are	be	VBP
work_26nhqvmztzhljeufl75hmtirqi	19	6	often	often	RB
work_26nhqvmztzhljeufl75hmtirqi	19	7	being	be	VBG
work_26nhqvmztzhljeufl75hmtirqi	19	8	applied	apply	VBN
work_26nhqvmztzhljeufl75hmtirqi	19	9	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	19	10	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	19	11	quite	quite	RB
work_26nhqvmztzhljeufl75hmtirqi	19	12	different	different	JJ
work_26nhqvmztzhljeufl75hmtirqi	19	13	from	from	IN
work_26nhqvmztzhljeufl75hmtirqi	19	14	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	19	15	original	original	JJ
work_26nhqvmztzhljeufl75hmtirqi	19	16	study	study	NN
work_26nhqvmztzhljeufl75hmtirqi	19	17	group	group	NN
work_26nhqvmztzhljeufl75hmtirqi	19	18	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	20	1	More	more	RBR
work_26nhqvmztzhljeufl75hmtirqi	20	2	concerning	concern	VBG
work_26nhqvmztzhljeufl75hmtirqi	20	3	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	20	4	these	these	DT
work_26nhqvmztzhljeufl75hmtirqi	20	5	trials	trial	NNS
work_26nhqvmztzhljeufl75hmtirqi	20	6	were	be	VBD
work_26nhqvmztzhljeufl75hmtirqi	20	7	designed	design	VBN
work_26nhqvmztzhljeufl75hmtirqi	20	8	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	20	9	look	look	VB
work_26nhqvmztzhljeufl75hmtirqi	20	10	at	at	IN
work_26nhqvmztzhljeufl75hmtirqi	20	11	engraftment	engraftment	NN
work_26nhqvmztzhljeufl75hmtirqi	20	12	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	20	13	GVHD	GVHD	NNP
work_26nhqvmztzhljeufl75hmtirqi	20	14	pro-	pro-	NN
work_26nhqvmztzhljeufl75hmtirqi	20	15	phylaxis	phylaxi	NNS
work_26nhqvmztzhljeufl75hmtirqi	20	16	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	20	17	not	not	RB
work_26nhqvmztzhljeufl75hmtirqi	20	18	at	at	IN
work_26nhqvmztzhljeufl75hmtirqi	20	19	effective	effective	JJ
work_26nhqvmztzhljeufl75hmtirqi	20	20	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	20	21	tapering	taper	VBG
work_26nhqvmztzhljeufl75hmtirqi	20	22	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	21	1	Although	although	IN
work_26nhqvmztzhljeufl75hmtirqi	21	2	some	some	DT
work_26nhqvmztzhljeufl75hmtirqi	21	3	do	do	VBP
work_26nhqvmztzhljeufl75hmtirqi	21	4	report	report	VB
work_26nhqvmztzhljeufl75hmtirqi	21	5	rates	rate	NNS
work_26nhqvmztzhljeufl75hmtirqi	21	6	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	21	7	cGVHD	cgvhd	NN
work_26nhqvmztzhljeufl75hmtirqi	21	8	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	21	9	none	none	NN
work_26nhqvmztzhljeufl75hmtirqi	21	10	truly	truly	RB
work_26nhqvmztzhljeufl75hmtirqi	21	11	report	report	VBP
work_26nhqvmztzhljeufl75hmtirqi	21	12	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	21	13	bur-	bur-	NN
work_26nhqvmztzhljeufl75hmtirqi	21	14	den	den	NN
work_26nhqvmztzhljeufl75hmtirqi	21	15	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	21	16	GVHD	GVHD	NNP
work_26nhqvmztzhljeufl75hmtirqi	21	17	occurring	occur	VBG
work_26nhqvmztzhljeufl75hmtirqi	21	18	on	on	IN
work_26nhqvmztzhljeufl75hmtirqi	21	19	taper	taper	NN
work_26nhqvmztzhljeufl75hmtirqi	21	20	or	or	CC
work_26nhqvmztzhljeufl75hmtirqi	21	21	how	how	WRB
work_26nhqvmztzhljeufl75hmtirqi	21	22	many	many	JJ
work_26nhqvmztzhljeufl75hmtirqi	21	23	pa-	pa-	NN
work_26nhqvmztzhljeufl75hmtirqi	21	24	tients	tient	NNS
work_26nhqvmztzhljeufl75hmtirqi	21	25	required	require	VBN
work_26nhqvmztzhljeufl75hmtirqi	21	26	reinstitution	reinstitution	NN
work_26nhqvmztzhljeufl75hmtirqi	21	27	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	21	28	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	21	29	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	22	1	Thus	thus	RB
work_26nhqvmztzhljeufl75hmtirqi	22	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	22	3	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	22	4	physicians	physician	NNS
work_26nhqvmztzhljeufl75hmtirqi	22	5	must	must	MD
work_26nhqvmztzhljeufl75hmtirqi	22	6	make	make	VB
work_26nhqvmztzhljeufl75hmtirqi	22	7	their	-PRON-	PRP$
work_26nhqvmztzhljeufl75hmtirqi	22	8	best	good	JJS
work_26nhqvmztzhljeufl75hmtirqi	22	9	guess	guess	VB
work_26nhqvmztzhljeufl75hmtirqi	22	10	how	how	WRB
work_26nhqvmztzhljeufl75hmtirqi	22	11	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	22	12	adapt	adapt	VB
work_26nhqvmztzhljeufl75hmtirqi	22	13	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	22	14	published	publish	VBN
work_26nhqvmztzhljeufl75hmtirqi	22	15	regimens	regimen	NNS
work_26nhqvmztzhljeufl75hmtirqi	22	16	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	22	17	their	-PRON-	PRP$
work_26nhqvmztzhljeufl75hmtirqi	22	18	diverse	diverse	JJ
work_26nhqvmztzhljeufl75hmtirqi	22	19	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	22	20	types	type	NNS
work_26nhqvmztzhljeufl75hmtirqi	22	21	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	23	1	Second	second	JJ
work_26nhqvmztzhljeufl75hmtirqi	23	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	23	3	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	23	4	patient	patient	NN
work_26nhqvmztzhljeufl75hmtirqi	23	5	population	population	NN
work_26nhqvmztzhljeufl75hmtirqi	23	6	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	23	7	also	also	RB
work_26nhqvmztzhljeufl75hmtirqi	23	8	changed	change	VBN
work_26nhqvmztzhljeufl75hmtirqi	23	9	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	23	10	expanding	expand	VBG
work_26nhqvmztzhljeufl75hmtirqi	23	11	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	23	12	include	include	VB
work_26nhqvmztzhljeufl75hmtirqi	23	13	older	old	JJR
work_26nhqvmztzhljeufl75hmtirqi	23	14	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	23	15	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	23	16	pa-	pa-	NN
work_26nhqvmztzhljeufl75hmtirqi	23	17	tients	tient	NNS
work_26nhqvmztzhljeufl75hmtirqi	23	18	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	23	19	multiple	multiple	JJ
work_26nhqvmztzhljeufl75hmtirqi	23	20	medical	medical	JJ
work_26nhqvmztzhljeufl75hmtirqi	23	21	illnesses	illness	NNS
work_26nhqvmztzhljeufl75hmtirqi	23	22	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	23	23	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	23	24	marginal	marginal	JJ
work_26nhqvmztzhljeufl75hmtirqi	23	25	organ	organ	NN
work_26nhqvmztzhljeufl75hmtirqi	23	26	reserves	reserve	NNS
work_26nhqvmztzhljeufl75hmtirqi	23	27	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	24	1	This	this	DT
work_26nhqvmztzhljeufl75hmtirqi	24	2	group	group	NN
work_26nhqvmztzhljeufl75hmtirqi	24	3	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	24	4	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	24	5	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	24	6	less	less	JJR
work_26nhqvmztzhljeufl75hmtirqi	24	7	immu-	immu-	JJ
work_26nhqvmztzhljeufl75hmtirqi	24	8	nologic	nologic	JJ
work_26nhqvmztzhljeufl75hmtirqi	24	9	plasticity	plasticity	NN
work_26nhqvmztzhljeufl75hmtirqi	24	10	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	24	11	tolerance	tolerance	NN
work_26nhqvmztzhljeufl75hmtirqi	24	12	induction	induction	NN
work_26nhqvmztzhljeufl75hmtirqi	24	13	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	24	14	likely	likely	RB
work_26nhqvmztzhljeufl75hmtirqi	24	15	more	more	RBR
work_26nhqvmztzhljeufl75hmtirqi	24	16	difficult	difficult	JJ
work_26nhqvmztzhljeufl75hmtirqi	24	17	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	25	1	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	25	2	growth	growth	NN
work_26nhqvmztzhljeufl75hmtirqi	25	3	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	25	4	cord	cord	NN
work_26nhqvmztzhljeufl75hmtirqi	25	5	blood	blood	NN
work_26nhqvmztzhljeufl75hmtirqi	25	6	transplants	transplant	NNS
work_26nhqvmztzhljeufl75hmtirqi	25	7	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	25	8	introduced	introduce	VBN
work_26nhqvmztzhljeufl75hmtirqi	25	9	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	25	10	group	group	NN
work_26nhqvmztzhljeufl75hmtirqi	25	11	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	25	12	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	25	13	potential	potential	NN
work_26nhqvmztzhljeufl75hmtirqi	25	14	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	25	15	greater	great	JJR
work_26nhqvmztzhljeufl75hmtirqi	25	16	immunologic	immunologic	JJ
work_26nhqvmztzhljeufl75hmtirqi	25	17	plasticity	plasticity	NN
work_26nhqvmztzhljeufl75hmtirqi	25	18	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	26	1	Strikingly	strikingly	RB
work_26nhqvmztzhljeufl75hmtirqi	26	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	26	3	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	26	4	basic	basic	JJ
work_26nhqvmztzhljeufl75hmtirqi	26	5	practice	practice	NN
work_26nhqvmztzhljeufl75hmtirqi	26	6	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	26	7	transplantation	transplantation	NN
work_26nhqvmztzhljeufl75hmtirqi	26	8	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	26	9	many	many	JJ
work_26nhqvmztzhljeufl75hmtirqi	26	10	ways	way	NNS
work_26nhqvmztzhljeufl75hmtirqi	26	11	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	26	12	not	not	RB
work_26nhqvmztzhljeufl75hmtirqi	26	13	changed	change	VBN
work_26nhqvmztzhljeufl75hmtirqi	26	14	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	27	1	Care	care	NN
work_26nhqvmztzhljeufl75hmtirqi	27	2	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	27	3	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	27	4	patient	patient	NN
work_26nhqvmztzhljeufl75hmtirqi	27	5	receiving	receive	VBG
work_26nhqvmztzhljeufl75hmtirqi	27	6	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	27	7	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	27	8	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	27	9	usually	usually	RB
work_26nhqvmztzhljeufl75hmtirqi	27	10	trans-	trans-	JJ
work_26nhqvmztzhljeufl75hmtirqi	27	11	ferred	ferre	VBN
work_26nhqvmztzhljeufl75hmtirqi	27	12	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	27	13	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	27	14	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	27	15	center	center	NN
work_26nhqvmztzhljeufl75hmtirqi	27	16	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	27	17	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	27	18	limited	limited	JJ
work_26nhqvmztzhljeufl75hmtirqi	27	19	period	period	NN
work_26nhqvmztzhljeufl75hmtirqi	27	20	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	27	21	time	time	NN
work_26nhqvmztzhljeufl75hmtirqi	27	22	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	28	1	This	this	DT
work_26nhqvmztzhljeufl75hmtirqi	28	2	care	care	NN
work_26nhqvmztzhljeufl75hmtirqi	28	3	model	model	NN
work_26nhqvmztzhljeufl75hmtirqi	28	4	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	28	5	long	long	RB
work_26nhqvmztzhljeufl75hmtirqi	28	6	impeded	impede	VBN
work_26nhqvmztzhljeufl75hmtirqi	28	7	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	28	8	study	study	NN
work_26nhqvmztzhljeufl75hmtirqi	28	9	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	28	10	care	care	NN
work_26nhqvmztzhljeufl75hmtirqi	28	11	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	28	12	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	28	13	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	28	14	cGVHD	cgvhd	NN
work_26nhqvmztzhljeufl75hmtirqi	28	15	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	29	1	It	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	29	2	certainly	certainly	RB
work_26nhqvmztzhljeufl75hmtirqi	29	3	contrib-	contrib-	VBP
work_26nhqvmztzhljeufl75hmtirqi	29	4	utes	ute	NNS
work_26nhqvmztzhljeufl75hmtirqi	29	5	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	29	6	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	29	7	lack	lack	NN
work_26nhqvmztzhljeufl75hmtirqi	29	8	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	29	9	research	research	NN
work_26nhqvmztzhljeufl75hmtirqi	29	10	into	into	IN
work_26nhqvmztzhljeufl75hmtirqi	29	11	withdraw	withdraw	NN
work_26nhqvmztzhljeufl75hmtirqi	29	12	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	29	13	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	29	14	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	30	1	Finally	finally	RB
work_26nhqvmztzhljeufl75hmtirqi	30	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	30	3	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	30	4	few	few	JJ
work_26nhqvmztzhljeufl75hmtirqi	30	5	trials	trial	NNS
work_26nhqvmztzhljeufl75hmtirqi	30	6	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	30	7	prolonged	prolong	VBN
work_26nhqvmztzhljeufl75hmtirqi	30	8	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	30	9	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	30	10	an	an	DT
work_26nhqvmztzhljeufl75hmtirqi	30	11	attempt	attempt	NN
work_26nhqvmztzhljeufl75hmtirqi	30	12	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	30	13	reduce	reduce	VB
work_26nhqvmztzhljeufl75hmtirqi	30	14	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	30	15	rates	rate	NNS
work_26nhqvmztzhljeufl75hmtirqi	30	16	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	30	17	recurrent	recurrent	JJ
work_26nhqvmztzhljeufl75hmtirqi	30	18	aGVHD	aGVHD	NNS
work_26nhqvmztzhljeufl75hmtirqi	30	19	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	30	20	cGVHD	cGVHD	NNS
work_26nhqvmztzhljeufl75hmtirqi	30	21	have	have	VBP
work_26nhqvmztzhljeufl75hmtirqi	30	22	produced	produce	VBN
work_26nhqvmztzhljeufl75hmtirqi	30	23	mixed	mix	VBN
work_26nhqvmztzhljeufl75hmtirqi	30	24	results	result	NNS
work_26nhqvmztzhljeufl75hmtirqi	30	25	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	30	26	no	no	DT
work_26nhqvmztzhljeufl75hmtirqi	30	27	clear	clear	JJ
work_26nhqvmztzhljeufl75hmtirqi	30	28	indication	indication	NN
work_26nhqvmztzhljeufl75hmtirqi	30	29	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	30	30	longer	long	JJR
work_26nhqvmztzhljeufl75hmtirqi	30	31	standard	standard	NN
work_26nhqvmztzhljeufl75hmtirqi	30	32	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	30	33	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	30	34	better	well	JJR
work_26nhqvmztzhljeufl75hmtirqi	30	35	[	[	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	30	36	2	2	CD
work_26nhqvmztzhljeufl75hmtirqi	30	37	]	]	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	30	38	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	31	1	Likewise	likewise	RB
work_26nhqvmztzhljeufl75hmtirqi	31	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	31	3	attempts	attempt	NNS
work_26nhqvmztzhljeufl75hmtirqi	31	4	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	31	5	prevent	prevent	VB
work_26nhqvmztzhljeufl75hmtirqi	31	6	cGVHD	cgvhd	NN
work_26nhqvmztzhljeufl75hmtirqi	31	7	using	use	VBG
work_26nhqvmztzhljeufl75hmtirqi	31	8	immunomodulatory	immunomodulatory	JJ
work_26nhqvmztzhljeufl75hmtirqi	31	9	agents	agent	NNS
work_26nhqvmztzhljeufl75hmtirqi	31	10	have	have	VBP
work_26nhqvmztzhljeufl75hmtirqi	31	11	not	not	RB
work_26nhqvmztzhljeufl75hmtirqi	31	12	proven	prove	VBN
work_26nhqvmztzhljeufl75hmtirqi	31	13	successful	successful	JJ
work_26nhqvmztzhljeufl75hmtirqi	31	14	[	[	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	31	15	3	3	CD
work_26nhqvmztzhljeufl75hmtirqi	31	16	]	]	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	31	17	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	32	1	Indeed	indeed	RB
work_26nhqvmztzhljeufl75hmtirqi	32	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	32	3	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	32	4	recent	recent	JJ
work_26nhqvmztzhljeufl75hmtirqi	32	5	premature	premature	JJ
work_26nhqvmztzhljeufl75hmtirqi	32	6	closure	closure	NN
work_26nhqvmztzhljeufl75hmtirqi	32	7	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	32	8	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	32	9	HOVON	HOVON	NNP
work_26nhqvmztzhljeufl75hmtirqi	32	10	76	76	CD
work_26nhqvmztzhljeufl75hmtirqi	32	11	trial	trial	NN
work_26nhqvmztzhljeufl75hmtirqi	32	12	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	32	13	Lenali-	Lenali-	NNP
work_26nhqvmztzhljeufl75hmtirqi	32	14	domide	domide	NN
work_26nhqvmztzhljeufl75hmtirqi	32	15	after	after	IN
work_26nhqvmztzhljeufl75hmtirqi	32	16	reduced	reduce	VBN
work_26nhqvmztzhljeufl75hmtirqi	32	17	-	-	HYPH
work_26nhqvmztzhljeufl75hmtirqi	32	18	intensity	intensity	NN
work_26nhqvmztzhljeufl75hmtirqi	32	19	allogeneic	allogeneic	NNS
work_26nhqvmztzhljeufl75hmtirqi	32	20	transplanta-	transplanta-	JJ
work_26nhqvmztzhljeufl75hmtirqi	32	21	tion	tion	NN
work_26nhqvmztzhljeufl75hmtirqi	32	22	highlights	highlight	NNS
work_26nhqvmztzhljeufl75hmtirqi	32	23	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	32	24	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	32	25	unanticipated	unanticipated	JJ
work_26nhqvmztzhljeufl75hmtirqi	32	26	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	32	27	induction	induction	NN
work_26nhqvmztzhljeufl75hmtirqi	32	28	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	32	29	aGVHD	agvhd	NN
work_26nhqvmztzhljeufl75hmtirqi	32	30	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	32	31	may	may	MD
work_26nhqvmztzhljeufl75hmtirqi	32	32	occur	occur	VB
work_26nhqvmztzhljeufl75hmtirqi	32	33	even	even	RB
work_26nhqvmztzhljeufl75hmtirqi	32	34	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	32	35	agents	agent	NNS
work_26nhqvmztzhljeufl75hmtirqi	32	36	that	that	WDT
work_26nhqvmztzhljeufl75hmtirqi	32	37	have	have	VBP
work_26nhqvmztzhljeufl75hmtirqi	32	38	been	be	VBN
work_26nhqvmztzhljeufl75hmtirqi	32	39	well	well	RB
work_26nhqvmztzhljeufl75hmtirqi	32	40	tolerated	tolerate	VBN
work_26nhqvmztzhljeufl75hmtirqi	32	41	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	32	42	other	other	JJ
work_26nhqvmztzhljeufl75hmtirqi	32	43	posttransplant	posttransplant	JJ
work_26nhqvmztzhljeufl75hmtirqi	32	44	situations	situation	NNS
work_26nhqvmztzhljeufl75hmtirqi	32	45	(	(	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	32	46	relapse	relapse	NN
work_26nhqvmztzhljeufl75hmtirqi	32	47	or	or	CC
work_26nhqvmztzhljeufl75hmtirqi	32	48	progression	progression	NN
work_26nhqvmztzhljeufl75hmtirqi	32	49	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	32	50	multiple	multiple	JJ
work_26nhqvmztzhljeufl75hmtirqi	32	51	myeloma	myeloma	NN
work_26nhqvmztzhljeufl75hmtirqi	32	52	)	)	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	32	53	[	[	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	32	54	4	4	CD
work_26nhqvmztzhljeufl75hmtirqi	32	55	]	]	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	32	56	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	33	1	Is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	33	2	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	33	3	situation	situation	NN
work_26nhqvmztzhljeufl75hmtirqi	33	4	then	then	RB
work_26nhqvmztzhljeufl75hmtirqi	33	5	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	33	6	hopeless	hopeless	JJ
work_26nhqvmztzhljeufl75hmtirqi	33	7	muddle	muddle	NN
work_26nhqvmztzhljeufl75hmtirqi	33	8	?	?	.
work_26nhqvmztzhljeufl75hmtirqi	34	1	Certainly	certainly	RB
work_26nhqvmztzhljeufl75hmtirqi	34	2	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	34	3	Pidala	Pidala	NNP
work_26nhqvmztzhljeufl75hmtirqi	34	4	paper	paper	NN
work_26nhqvmztzhljeufl75hmtirqi	34	5	[	[	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	34	6	1	1	CD
work_26nhqvmztzhljeufl75hmtirqi	34	7	]	]	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	34	8	shows	show	VBZ
work_26nhqvmztzhljeufl75hmtirqi	34	9	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	34	10	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	34	11	physicians	physician	NNS
work_26nhqvmztzhljeufl75hmtirqi	34	12	are	be	VBP
work_26nhqvmztzhljeufl75hmtirqi	34	13	extremely	extremely	RB
work_26nhqvmztzhljeufl75hmtirqi	34	14	uncomfortable	uncomfortable	JJ
work_26nhqvmztzhljeufl75hmtirqi	34	15	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	34	16	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	34	17	current	current	JJ
work_26nhqvmztzhljeufl75hmtirqi	34	18	state	state	NN
work_26nhqvmztzhljeufl75hmtirqi	34	19	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	34	20	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	34	21	there	there	EX
work_26nhqvmztzhljeufl75hmtirqi	34	22	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	34	23	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	34	24	wide	wide	JJ
work_26nhqvmztzhljeufl75hmtirqi	34	25	variation	variation	NN
work_26nhqvmztzhljeufl75hmtirqi	34	26	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	34	27	how	how	WRB
work_26nhqvmztzhljeufl75hmtirqi	34	28	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	34	29	are	be	VBP
work_26nhqvmztzhljeufl75hmtirqi	34	30	managed	manage	VBN
work_26nhqvmztzhljeufl75hmtirqi	34	31	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	35	1	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	35	2	investigators	investigator	NNS
work_26nhqvmztzhljeufl75hmtirqi	35	3	suggest	suggest	VBP
work_26nhqvmztzhljeufl75hmtirqi	35	4	several	several	JJ
work_26nhqvmztzhljeufl75hmtirqi	35	5	possible	possible	JJ
work_26nhqvmztzhljeufl75hmtirqi	35	6	approaches	approach	NNS
work_26nhqvmztzhljeufl75hmtirqi	35	7	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	35	8	improve	improve	VB
work_26nhqvmztzhljeufl75hmtirqi	35	9	our	-PRON-	PRP$
work_26nhqvmztzhljeufl75hmtirqi	35	10	current	current	JJ
work_26nhqvmztzhljeufl75hmtirqi	35	11	state	state	NN
work_26nhqvmztzhljeufl75hmtirqi	35	12	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	35	13	ignorance	ignorance	NN
work_26nhqvmztzhljeufl75hmtirqi	35	14	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	36	1	Retrospective	retrospective	JJ
work_26nhqvmztzhljeufl75hmtirqi	36	2	studies	study	NNS
work_26nhqvmztzhljeufl75hmtirqi	36	3	could	could	MD
work_26nhqvmztzhljeufl75hmtirqi	36	4	examine	examine	VB
work_26nhqvmztzhljeufl75hmtirqi	36	5	successful	successful	JJ
work_26nhqvmztzhljeufl75hmtirqi	36	6	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	36	7	1417	1417	CD
work_26nhqvmztzhljeufl75hmtirqi	36	8	mailto:gbvogelsang@gmail.com	mailto:gbvogelsang@gmail.com	ADD
work_26nhqvmztzhljeufl75hmtirqi	36	9	http://dx.doi.org/10.1016/j.bbmt.2011.08.004	http://dx.doi.org/10.1016/j.bbmt.2011.08.004	NNP
work_26nhqvmztzhljeufl75hmtirqi	36	10	1418	1418	CD
work_26nhqvmztzhljeufl75hmtirqi	36	11	Biol	Biol	NNP
work_26nhqvmztzhljeufl75hmtirqi	36	12	Blood	Blood	NNP
work_26nhqvmztzhljeufl75hmtirqi	36	13	Marrow	Marrow	NNP
work_26nhqvmztzhljeufl75hmtirqi	36	14	Transplant	Transplant	NNP
work_26nhqvmztzhljeufl75hmtirqi	36	15	17:1417	17:1417	CD
work_26nhqvmztzhljeufl75hmtirqi	36	16	-	-	SYM
work_26nhqvmztzhljeufl75hmtirqi	36	17	1418	1418	CD
work_26nhqvmztzhljeufl75hmtirqi	36	18	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	36	19	2011G.	2011g.	CD
work_26nhqvmztzhljeufl75hmtirqi	37	1	Vogelsang	Vogelsang	NNP
work_26nhqvmztzhljeufl75hmtirqi	37	2	discontinuation	discontinuation	NN
work_26nhqvmztzhljeufl75hmtirqi	37	3	rates	rate	NNS
work_26nhqvmztzhljeufl75hmtirqi	37	4	according	accord	VBG
work_26nhqvmztzhljeufl75hmtirqi	37	5	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	37	6	tapering	tapering	NN
work_26nhqvmztzhljeufl75hmtirqi	37	7	schedule	schedule	NN
work_26nhqvmztzhljeufl75hmtirqi	37	8	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	38	1	Prospective	prospective	JJ
work_26nhqvmztzhljeufl75hmtirqi	38	2	observational	observational	JJ
work_26nhqvmztzhljeufl75hmtirqi	38	3	studies	study	NNS
work_26nhqvmztzhljeufl75hmtirqi	38	4	could	could	MD
work_26nhqvmztzhljeufl75hmtirqi	38	5	record	record	VB
work_26nhqvmztzhljeufl75hmtirqi	38	6	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	38	7	IS	IS	NNP
work_26nhqvmztzhljeufl75hmtirqi	38	8	taper	taper	NN
work_26nhqvmztzhljeufl75hmtirqi	38	9	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	38	10	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	38	11	associated	associate	VBN
work_26nhqvmztzhljeufl75hmtirqi	38	12	outcomes	outcome	NNS
work_26nhqvmztzhljeufl75hmtirqi	38	13	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	39	1	They	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	39	2	suggest	suggest	VBP
work_26nhqvmztzhljeufl75hmtirqi	39	3	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	39	4	this	this	DT
work_26nhqvmztzhljeufl75hmtirqi	39	5	data	data	NN
work_26nhqvmztzhljeufl75hmtirqi	39	6	be	be	VB
work_26nhqvmztzhljeufl75hmtirqi	39	7	used	use	VBN
work_26nhqvmztzhljeufl75hmtirqi	39	8	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	39	9	design	design	VB
work_26nhqvmztzhljeufl75hmtirqi	39	10	prospective	prospective	JJ
work_26nhqvmztzhljeufl75hmtirqi	39	11	randomized	randomized	JJ
work_26nhqvmztzhljeufl75hmtirqi	39	12	trial	trial	NN
work_26nhqvmztzhljeufl75hmtirqi	39	13	comparing	compare	VBG
work_26nhqvmztzhljeufl75hmtirqi	39	14	best	good	JJS
work_26nhqvmztzhljeufl75hmtirqi	39	15	approaches	approach	NNS
work_26nhqvmztzhljeufl75hmtirqi	39	16	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	39	17	tapering	taper	VBG
work_26nhqvmztzhljeufl75hmtirqi	39	18	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	39	19	dis-	dis-	IN
work_26nhqvmztzhljeufl75hmtirqi	39	20	continuation	continuation	NN
work_26nhqvmztzhljeufl75hmtirqi	39	21	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	39	22	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	39	23	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	40	1	My	-PRON-	PRP$
work_26nhqvmztzhljeufl75hmtirqi	40	2	own	own	JJ
work_26nhqvmztzhljeufl75hmtirqi	40	3	belief	belief	NN
work_26nhqvmztzhljeufl75hmtirqi	40	4	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	40	5	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	40	6	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	40	7	often	often	RB
work_26nhqvmztzhljeufl75hmtirqi	40	8	competing	compete	VBG
work_26nhqvmztzhljeufl75hmtirqi	40	9	factors	factor	NNS
work_26nhqvmztzhljeufl75hmtirqi	40	10	listed	list	VBN
work_26nhqvmztzhljeufl75hmtirqi	40	11	above	above	IN
work_26nhqvmztzhljeufl75hmtirqi	40	12	that	that	DT
work_26nhqvmztzhljeufl75hmtirqi	40	13	created	create	VBD
work_26nhqvmztzhljeufl75hmtirqi	40	14	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	40	15	muddle	muddle	NN
work_26nhqvmztzhljeufl75hmtirqi	40	16	make	make	VB
work_26nhqvmztzhljeufl75hmtirqi	40	17	prospective	prospective	JJ
work_26nhqvmztzhljeufl75hmtirqi	40	18	clinical	clinical	JJ
work_26nhqvmztzhljeufl75hmtirqi	40	19	trials	trial	NNS
work_26nhqvmztzhljeufl75hmtirqi	40	20	comparing	compare	VBG
work_26nhqvmztzhljeufl75hmtirqi	40	21	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	40	22	with-	with-	NN
work_26nhqvmztzhljeufl75hmtirqi	40	23	draw	draw	NN
work_26nhqvmztzhljeufl75hmtirqi	40	24	strategies	strategy	NNS
work_26nhqvmztzhljeufl75hmtirqi	40	25	identified	identify	VBN
work_26nhqvmztzhljeufl75hmtirqi	40	26	as	as	IN
work_26nhqvmztzhljeufl75hmtirqi	40	27	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	40	28	‘	'	``
work_26nhqvmztzhljeufl75hmtirqi	40	29	‘	'	``
work_26nhqvmztzhljeufl75hmtirqi	40	30	best	good	JJS
work_26nhqvmztzhljeufl75hmtirqi	40	31	’	'	''
work_26nhqvmztzhljeufl75hmtirqi	40	32	’	'	''
work_26nhqvmztzhljeufl75hmtirqi	40	33	extremely	extremely	RB
work_26nhqvmztzhljeufl75hmtirqi	40	34	com-	com-	NN
work_26nhqvmztzhljeufl75hmtirqi	40	35	plicated	plicate	VBD
work_26nhqvmztzhljeufl75hmtirqi	40	36	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	40	37	time	time	NN
work_26nhqvmztzhljeufl75hmtirqi	40	38	consuming	consuming	NN
work_26nhqvmztzhljeufl75hmtirqi	40	39	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	40	40	expensive	expensive	JJ
work_26nhqvmztzhljeufl75hmtirqi	40	41	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	40	42	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	40	43	may	may	MD
work_26nhqvmztzhljeufl75hmtirqi	40	44	still	still	RB
work_26nhqvmztzhljeufl75hmtirqi	40	45	produce	produce	VB
work_26nhqvmztzhljeufl75hmtirqi	40	46	equivocal	equivocal	JJ
work_26nhqvmztzhljeufl75hmtirqi	40	47	results	result	NNS
work_26nhqvmztzhljeufl75hmtirqi	40	48	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	41	1	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	41	2	investigators	investigator	NNS
work_26nhqvmztzhljeufl75hmtirqi	41	3	suggest	suggest	VBP
work_26nhqvmztzhljeufl75hmtirqi	41	4	another	another	DT
work_26nhqvmztzhljeufl75hmtirqi	41	5	path	path	NN
work_26nhqvmztzhljeufl75hmtirqi	41	6	that	that	WDT
work_26nhqvmztzhljeufl75hmtirqi	41	7	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	41	8	more	more	RBR
work_26nhqvmztzhljeufl75hmtirqi	41	9	likely	likely	JJ
work_26nhqvmztzhljeufl75hmtirqi	41	10	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	41	11	be	be	VB
work_26nhqvmztzhljeufl75hmtirqi	41	12	fruitful	fruitful	JJ
work_26nhqvmztzhljeufl75hmtirqi	41	13	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	42	1	If	if	IN
work_26nhqvmztzhljeufl75hmtirqi	42	2	vali-	vali-	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	3	dated	dated	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	4	biomarkers	biomarker	NNS
work_26nhqvmztzhljeufl75hmtirqi	42	5	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	42	6	post	post	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	7	-	-	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	8	HCT	hct	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	9	immune	immune	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	10	tolerance	tolerance	NN
work_26nhqvmztzhljeufl75hmtirqi	42	11	can	can	MD
work_26nhqvmztzhljeufl75hmtirqi	42	12	be	be	VB
work_26nhqvmztzhljeufl75hmtirqi	42	13	developed	develop	VBN
work_26nhqvmztzhljeufl75hmtirqi	42	14	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	42	15	these	these	DT
work_26nhqvmztzhljeufl75hmtirqi	42	16	could	could	MD
work_26nhqvmztzhljeufl75hmtirqi	42	17	be	be	VB
work_26nhqvmztzhljeufl75hmtirqi	42	18	used	use	VBN
work_26nhqvmztzhljeufl75hmtirqi	42	19	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	42	20	generate	generate	VB
work_26nhqvmztzhljeufl75hmtirqi	42	21	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	42	22	personalized	personalized	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	23	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	42	24	informed	informed	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	25	strategy	strategy	NN
work_26nhqvmztzhljeufl75hmtirqi	42	26	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	42	27	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	42	28	discontin-	discontin-	JJ
work_26nhqvmztzhljeufl75hmtirqi	42	29	uation	uation	NN
work_26nhqvmztzhljeufl75hmtirqi	42	30	after	after	IN
work_26nhqvmztzhljeufl75hmtirqi	42	31	allo	allo	NNP
work_26nhqvmztzhljeufl75hmtirqi	42	32	HCT	HCT	NNP
work_26nhqvmztzhljeufl75hmtirqi	42	33	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	43	1	Our	-PRON-	PRP$
work_26nhqvmztzhljeufl75hmtirqi	43	2	understanding	understanding	NN
work_26nhqvmztzhljeufl75hmtirqi	43	3	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	43	4	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	43	5	genes	gene	NNS
work_26nhqvmztzhljeufl75hmtirqi	43	6	regulating	regulate	VBG
work_26nhqvmztzhljeufl75hmtirqi	43	7	tolerance	tolerance	NN
work_26nhqvmztzhljeufl75hmtirqi	43	8	after	after	IN
work_26nhqvmztzhljeufl75hmtirqi	43	9	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	43	10	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	43	11	improved	improve	VBN
work_26nhqvmztzhljeufl75hmtirqi	43	12	sig-	sig-	RB
work_26nhqvmztzhljeufl75hmtirqi	43	13	nificantly	nificantly	RB
work_26nhqvmztzhljeufl75hmtirqi	43	14	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	43	15	solid	solid	JJ
work_26nhqvmztzhljeufl75hmtirqi	43	16	organ	organ	NN
work_26nhqvmztzhljeufl75hmtirqi	43	17	transplantation	transplantation	NN
work_26nhqvmztzhljeufl75hmtirqi	43	18	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	44	1	As	as	IN
work_26nhqvmztzhljeufl75hmtirqi	44	2	summa-	summa-	NN
work_26nhqvmztzhljeufl75hmtirqi	44	3	rized	rize	VBN
work_26nhqvmztzhljeufl75hmtirqi	44	4	recently	recently	RB
work_26nhqvmztzhljeufl75hmtirqi	44	5	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	44	6	an	an	DT
work_26nhqvmztzhljeufl75hmtirqi	44	7	excellent	excellent	JJ
work_26nhqvmztzhljeufl75hmtirqi	44	8	review	review	NN
work_26nhqvmztzhljeufl75hmtirqi	44	9	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	44	10	this	this	DT
work_26nhqvmztzhljeufl75hmtirqi	44	11	journal	journal	NN
work_26nhqvmztzhljeufl75hmtirqi	44	12	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	44	13	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	44	14	current	current	JJ
work_26nhqvmztzhljeufl75hmtirqi	44	15	concept	concept	NN
work_26nhqvmztzhljeufl75hmtirqi	44	16	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	44	17	that	that	IN
work_26nhqvmztzhljeufl75hmtirqi	44	18	tolerant	tolerant	JJ
work_26nhqvmztzhljeufl75hmtirqi	44	19	solid	solid	JJ
work_26nhqvmztzhljeufl75hmtirqi	44	20	organ	organ	NN
work_26nhqvmztzhljeufl75hmtirqi	44	21	trans-	trans-	NN
work_26nhqvmztzhljeufl75hmtirqi	44	22	plant	plant	NN
work_26nhqvmztzhljeufl75hmtirqi	44	23	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	44	24	have	have	VBP
work_26nhqvmztzhljeufl75hmtirqi	44	25	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	44	26	state	state	NN
work_26nhqvmztzhljeufl75hmtirqi	44	27	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	44	28	immune	immune	JJ
work_26nhqvmztzhljeufl75hmtirqi	44	29	quiescence	quiescence	NN
work_26nhqvmztzhljeufl75hmtirqi	44	30	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	44	31	reduced	reduced	JJ
work_26nhqvmztzhljeufl75hmtirqi	44	32	expression	expression	NN
work_26nhqvmztzhljeufl75hmtirqi	44	33	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	44	34	costimulation	costimulation	NN
work_26nhqvmztzhljeufl75hmtirqi	44	35	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	44	36	immune	immune	JJ
work_26nhqvmztzhljeufl75hmtirqi	44	37	response	response	NN
work_26nhqvmztzhljeufl75hmtirqi	44	38	genes	gene	NNS
work_26nhqvmztzhljeufl75hmtirqi	44	39	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	44	40	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	44	41	upregulation	upregulation	NN
work_26nhqvmztzhljeufl75hmtirqi	44	42	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	44	43	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	44	44	cycle	cycle	NN
work_26nhqvmztzhljeufl75hmtirqi	44	45	control	control	NN
work_26nhqvmztzhljeufl75hmtirqi	44	46	genes	gene	NNS
work_26nhqvmztzhljeufl75hmtirqi	44	47	[	[	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	44	48	5	5	CD
work_26nhqvmztzhljeufl75hmtirqi	44	49	]	]	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	44	50	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	45	1	CD41CD251FoxP31	cd41cd251foxp31	LS
work_26nhqvmztzhljeufl75hmtirqi	45	2	regulatory	regulatory	JJ
work_26nhqvmztzhljeufl75hmtirqi	45	3	T	T	NNP
work_26nhqvmztzhljeufl75hmtirqi	45	4	cells	cell	NNS
work_26nhqvmztzhljeufl75hmtirqi	45	5	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	45	6	likely	likely	JJ
work_26nhqvmztzhljeufl75hmtirqi	45	7	natural	natural	JJ
work_26nhqvmztzhljeufl75hmtirqi	45	8	killer	killer	NN
work_26nhqvmztzhljeufl75hmtirqi	45	9	cells	cell	NNS
work_26nhqvmztzhljeufl75hmtirqi	45	10	also	also	RB
work_26nhqvmztzhljeufl75hmtirqi	45	11	play	play	VBP
work_26nhqvmztzhljeufl75hmtirqi	45	12	important	important	JJ
work_26nhqvmztzhljeufl75hmtirqi	45	13	roles	role	NNS
work_26nhqvmztzhljeufl75hmtirqi	45	14	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	45	15	tolerance	tolerance	NN
work_26nhqvmztzhljeufl75hmtirqi	45	16	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	46	1	Unfortunately	unfortunately	RB
work_26nhqvmztzhljeufl75hmtirqi	46	2	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	46	3	not	not	RB
work_26nhqvmztzhljeufl75hmtirqi	46	4	much	much	JJ
work_26nhqvmztzhljeufl75hmtirqi	46	5	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	46	6	known	know	VBN
work_26nhqvmztzhljeufl75hmtirqi	46	7	about	about	IN
work_26nhqvmztzhljeufl75hmtirqi	46	8	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	46	9	corresponding	correspond	VBG
work_26nhqvmztzhljeufl75hmtirqi	46	10	tolerant	tolerant	JJ
work_26nhqvmztzhljeufl75hmtirqi	46	11	stem	stem	NN
work_26nhqvmztzhljeufl75hmtirqi	46	12	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	46	13	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	46	14	pa-	pa-	XX
work_26nhqvmztzhljeufl75hmtirqi	46	15	tient	tient	NN
work_26nhqvmztzhljeufl75hmtirqi	46	16	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	46	17	but	but	CC
work_26nhqvmztzhljeufl75hmtirqi	46	18	these	these	DT
work_26nhqvmztzhljeufl75hmtirqi	46	19	same	same	JJ
work_26nhqvmztzhljeufl75hmtirqi	46	20	techniques	technique	NNS
work_26nhqvmztzhljeufl75hmtirqi	46	21	should	should	MD
work_26nhqvmztzhljeufl75hmtirqi	46	22	be	be	VB
work_26nhqvmztzhljeufl75hmtirqi	46	23	able	able	JJ
work_26nhqvmztzhljeufl75hmtirqi	46	24	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	46	25	de-	de-	VB
work_26nhqvmztzhljeufl75hmtirqi	46	26	termine	termine	VB
work_26nhqvmztzhljeufl75hmtirqi	46	27	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	46	28	genetic	genetic	JJ
work_26nhqvmztzhljeufl75hmtirqi	46	29	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	46	30	cellular	cellular	JJ
work_26nhqvmztzhljeufl75hmtirqi	46	31	profile	profile	NN
work_26nhqvmztzhljeufl75hmtirqi	46	32	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	46	33	tolerant	tolerant	JJ
work_26nhqvmztzhljeufl75hmtirqi	46	34	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	46	35	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	47	1	Should	Should	MD
work_26nhqvmztzhljeufl75hmtirqi	47	2	these	these	DT
work_26nhqvmztzhljeufl75hmtirqi	47	3	markers	marker	NNS
work_26nhqvmztzhljeufl75hmtirqi	47	4	be	be	VB
work_26nhqvmztzhljeufl75hmtirqi	47	5	validated	validate	VBN
work_26nhqvmztzhljeufl75hmtirqi	47	6	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	47	7	this	this	DT
work_26nhqvmztzhljeufl75hmtirqi	47	8	would	would	MD
work_26nhqvmztzhljeufl75hmtirqi	47	9	allow	allow	VB
work_26nhqvmztzhljeufl75hmtirqi	47	10	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	47	11	rationally	rationally	RB
work_26nhqvmztzhljeufl75hmtirqi	47	12	designed	design	VBN
work_26nhqvmztzhljeufl75hmtirqi	47	13	strategies	strategy	NNS
work_26nhqvmztzhljeufl75hmtirqi	47	14	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	47	15	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	47	16	discon-	discon-	NNP
work_26nhqvmztzhljeufl75hmtirqi	47	17	tinuance	tinuance	NN
work_26nhqvmztzhljeufl75hmtirqi	47	18	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	48	1	This	this	DT
work_26nhqvmztzhljeufl75hmtirqi	48	2	approach	approach	NN
work_26nhqvmztzhljeufl75hmtirqi	48	3	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	48	4	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	48	5	multiple	multiple	JJ
work_26nhqvmztzhljeufl75hmtirqi	48	6	benefits	benefit	NNS
work_26nhqvmztzhljeufl75hmtirqi	48	7	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	49	1	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	49	2	manipulation	manipulation	NN
work_26nhqvmztzhljeufl75hmtirqi	49	3	could	could	MD
work_26nhqvmztzhljeufl75hmtirqi	49	4	be	be	VB
work_26nhqvmztzhljeufl75hmtirqi	49	5	focused	focus	VBN
work_26nhqvmztzhljeufl75hmtirqi	49	6	on	on	IN
work_26nhqvmztzhljeufl75hmtirqi	49	7	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	49	8	nontolerant	nontolerant	JJ
work_26nhqvmztzhljeufl75hmtirqi	49	9	pa-	pa-	NN
work_26nhqvmztzhljeufl75hmtirqi	49	10	tients	tient	NNS
work_26nhqvmztzhljeufl75hmtirqi	49	11	who	who	WP
work_26nhqvmztzhljeufl75hmtirqi	49	12	have	have	VBP
work_26nhqvmztzhljeufl75hmtirqi	49	13	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	49	14	most	most	JJS
work_26nhqvmztzhljeufl75hmtirqi	49	15	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	49	16	gain	gain	VB
work_26nhqvmztzhljeufl75hmtirqi	49	17	from	from	IN
work_26nhqvmztzhljeufl75hmtirqi	49	18	success	success	NN
work_26nhqvmztzhljeufl75hmtirqi	49	19	while	while	IN
work_26nhqvmztzhljeufl75hmtirqi	49	20	sparing	spare	VBG
work_26nhqvmztzhljeufl75hmtirqi	49	21	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	49	22	cost	cost	NN
work_26nhqvmztzhljeufl75hmtirqi	49	23	and	and	CC
work_26nhqvmztzhljeufl75hmtirqi	49	24	toxicity	toxicity	NN
work_26nhqvmztzhljeufl75hmtirqi	49	25	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	49	26	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	49	27	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	49	28	that	that	DT
work_26nhqvmztzhljeufl75hmtirqi	49	29	group	group	NN
work_26nhqvmztzhljeufl75hmtirqi	49	30	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	49	31	patients	patient	NNS
work_26nhqvmztzhljeufl75hmtirqi	49	32	who	who	WP
work_26nhqvmztzhljeufl75hmtirqi	49	33	have	have	VBP
work_26nhqvmztzhljeufl75hmtirqi	49	34	already	already	RB
work_26nhqvmztzhljeufl75hmtirqi	49	35	achieved	achieve	VBN
work_26nhqvmztzhljeufl75hmtirqi	49	36	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	49	37	tolerant	tolerant	JJ
work_26nhqvmztzhljeufl75hmtirqi	49	38	state	state	NN
work_26nhqvmztzhljeufl75hmtirqi	49	39	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	50	1	These	these	DT
work_26nhqvmztzhljeufl75hmtirqi	50	2	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	50	3	manipulations	manipulation	NNS
work_26nhqvmztzhljeufl75hmtirqi	50	4	could	could	MD
work_26nhqvmztzhljeufl75hmtirqi	50	5	be	be	VB
work_26nhqvmztzhljeufl75hmtirqi	50	6	directed	direct	VBN
work_26nhqvmztzhljeufl75hmtirqi	50	7	at	at	IN
work_26nhqvmztzhljeufl75hmtirqi	50	8	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	50	9	iden-	iden-	NN
work_26nhqvmztzhljeufl75hmtirqi	50	10	tified	tifie	VBN
work_26nhqvmztzhljeufl75hmtirqi	50	11	defect	defect	NN
work_26nhqvmztzhljeufl75hmtirqi	50	12	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	51	1	This	this	DT
work_26nhqvmztzhljeufl75hmtirqi	51	2	approach	approach	NN
work_26nhqvmztzhljeufl75hmtirqi	51	3	would	would	MD
work_26nhqvmztzhljeufl75hmtirqi	51	4	also	also	RB
work_26nhqvmztzhljeufl75hmtirqi	51	5	avoid	avoid	VB
work_26nhqvmztzhljeufl75hmtirqi	51	6	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	51	7	diffi-	diffi-	NN
work_26nhqvmztzhljeufl75hmtirqi	51	8	culty	culty	JJ
work_26nhqvmztzhljeufl75hmtirqi	51	9	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	51	10	having	have	VBG
work_26nhqvmztzhljeufl75hmtirqi	51	11	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	51	12	test	test	VB
work_26nhqvmztzhljeufl75hmtirqi	51	13	IS	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	51	14	discontinuance	discontinuance	NN
work_26nhqvmztzhljeufl75hmtirqi	51	15	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	51	16	all	all	PDT
work_26nhqvmztzhljeufl75hmtirqi	51	17	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	51	18	diverse	diverse	JJ
work_26nhqvmztzhljeufl75hmtirqi	51	19	combinations	combination	NNS
work_26nhqvmztzhljeufl75hmtirqi	51	20	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	51	21	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	51	22	types	type	NNS
work_26nhqvmztzhljeufl75hmtirqi	51	23	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	52	1	To	to	TO
work_26nhqvmztzhljeufl75hmtirqi	52	2	close	close	VB
work_26nhqvmztzhljeufl75hmtirqi	52	3	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	52	4	another	another	DT
work_26nhqvmztzhljeufl75hmtirqi	52	5	quote	quote	NN
work_26nhqvmztzhljeufl75hmtirqi	52	6	from	from	IN
work_26nhqvmztzhljeufl75hmtirqi	52	7	Benjamin	Benjamin	NNP
work_26nhqvmztzhljeufl75hmtirqi	52	8	Franklin	Franklin	NNP
work_26nhqvmztzhljeufl75hmtirqi	52	9	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	52	10	‘	'	``
work_26nhqvmztzhljeufl75hmtirqi	52	11	‘	'	``
work_26nhqvmztzhljeufl75hmtirqi	52	12	Being	be	VBG
work_26nhqvmztzhljeufl75hmtirqi	52	13	ignorant	ignorant	JJ
work_26nhqvmztzhljeufl75hmtirqi	52	14	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	52	15	not	not	RB
work_26nhqvmztzhljeufl75hmtirqi	52	16	so	so	RB
work_26nhqvmztzhljeufl75hmtirqi	52	17	much	much	RB
work_26nhqvmztzhljeufl75hmtirqi	52	18	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	52	19	shame	shame	NN
work_26nhqvmztzhljeufl75hmtirqi	52	20	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	52	21	as	as	IN
work_26nhqvmztzhljeufl75hmtirqi	52	22	being	be	VBG
work_26nhqvmztzhljeufl75hmtirqi	52	23	unwilling	unwilling	JJ
work_26nhqvmztzhljeufl75hmtirqi	52	24	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	52	25	learn	learn	VB
work_26nhqvmztzhljeufl75hmtirqi	52	26	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	52	27	’	'	''
work_26nhqvmztzhljeufl75hmtirqi	52	28	’	'	''
work_26nhqvmztzhljeufl75hmtirqi	52	29	This	this	DT
work_26nhqvmztzhljeufl75hmtirqi	52	30	paper	paper	NN
work_26nhqvmztzhljeufl75hmtirqi	52	31	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	52	32	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	52	33	call	call	NN
work_26nhqvmztzhljeufl75hmtirqi	52	34	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	52	35	all	all	DT
work_26nhqvmztzhljeufl75hmtirqi	52	36	that	that	WDT
work_26nhqvmztzhljeufl75hmtirqi	52	37	we	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	52	38	have	have	VBP
work_26nhqvmztzhljeufl75hmtirqi	52	39	much	much	JJ
work_26nhqvmztzhljeufl75hmtirqi	52	40	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	52	41	learn	learn	VB
work_26nhqvmztzhljeufl75hmtirqi	52	42	before	before	IN
work_26nhqvmztzhljeufl75hmtirqi	52	43	we	-PRON-	PRP
work_26nhqvmztzhljeufl75hmtirqi	52	44	are	be	VBP
work_26nhqvmztzhljeufl75hmtirqi	52	45	able	able	JJ
work_26nhqvmztzhljeufl75hmtirqi	52	46	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	52	47	opti-	opti-	VB
work_26nhqvmztzhljeufl75hmtirqi	52	48	mally	mally	RB
work_26nhqvmztzhljeufl75hmtirqi	52	49	manage	manage	VB
work_26nhqvmztzhljeufl75hmtirqi	52	50	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	52	51	final	final	JJ
work_26nhqvmztzhljeufl75hmtirqi	52	52	step	step	NN
work_26nhqvmztzhljeufl75hmtirqi	52	53	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	52	54	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	52	55	stem	stem	NN
work_26nhqvmztzhljeufl75hmtirqi	52	56	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	52	57	transplant	transplant	NN
work_26nhqvmztzhljeufl75hmtirqi	52	58	procedure	procedure	NN
work_26nhqvmztzhljeufl75hmtirqi	52	59	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	53	1	ACKNOWLEDGMENTS	ACKNOWLEDGMENTS	NNP
work_26nhqvmztzhljeufl75hmtirqi	53	2	Financial	financial	JJ
work_26nhqvmztzhljeufl75hmtirqi	53	3	disclosure	disclosure	NN
work_26nhqvmztzhljeufl75hmtirqi	53	4	:	:	:
work_26nhqvmztzhljeufl75hmtirqi	53	5	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	53	6	authors	author	NNS
work_26nhqvmztzhljeufl75hmtirqi	53	7	has	have	VBZ
work_26nhqvmztzhljeufl75hmtirqi	53	8	nothing	nothing	NN
work_26nhqvmztzhljeufl75hmtirqi	53	9	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	53	10	de-	de-	VB
work_26nhqvmztzhljeufl75hmtirqi	53	11	clare	clare	VB
work_26nhqvmztzhljeufl75hmtirqi	53	12	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	54	1	REFERENCES	reference	NNS
work_26nhqvmztzhljeufl75hmtirqi	54	2	1	1	CD
work_26nhqvmztzhljeufl75hmtirqi	54	3	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	55	1	Pidala	Pidala	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	2	J	J	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	3	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	55	4	Lee	Lee	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	5	SJ	SJ	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	6	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	55	7	Quinn	Quinn	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	8	G	G	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	9	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	55	10	Jim	Jim	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	11	H	H	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	12	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	55	13	Kim	Kim	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	14	J	J	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	15	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	55	16	Anasetti	Anasetti	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	17	C.	C.	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	18	Variation	Variation	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	19	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	55	20	management	management	NN
work_26nhqvmztzhljeufl75hmtirqi	55	21	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	55	22	immune	immune	JJ
work_26nhqvmztzhljeufl75hmtirqi	55	23	suppression	suppression	NN
work_26nhqvmztzhljeufl75hmtirqi	55	24	after	after	IN
work_26nhqvmztzhljeufl75hmtirqi	55	25	allogeneic	allogeneic	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	26	hematopoi-	hematopoi-	NNP
work_26nhqvmztzhljeufl75hmtirqi	55	27	etic	etic	JJ
work_26nhqvmztzhljeufl75hmtirqi	55	28	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	55	29	transplantation	transplantation	NN
work_26nhqvmztzhljeufl75hmtirqi	55	30	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	56	1	Biol	Biol	NNP
work_26nhqvmztzhljeufl75hmtirqi	56	2	Blood	Blood	NNP
work_26nhqvmztzhljeufl75hmtirqi	56	3	Marrow	Marrow	NNP
work_26nhqvmztzhljeufl75hmtirqi	56	4	Transplant	Transplant	NNP
work_26nhqvmztzhljeufl75hmtirqi	56	5	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	57	1	2001	2001	CD
work_26nhqvmztzhljeufl75hmtirqi	57	2	April	April	NNP
work_26nhqvmztzhljeufl75hmtirqi	57	3	11	11	CD
work_26nhqvmztzhljeufl75hmtirqi	57	4	[	[	-LRB-
work_26nhqvmztzhljeufl75hmtirqi	57	5	Epup	epup	NN
work_26nhqvmztzhljeufl75hmtirqi	57	6	ahead	ahead	RB
work_26nhqvmztzhljeufl75hmtirqi	57	7	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	57	8	print	print	NN
work_26nhqvmztzhljeufl75hmtirqi	57	9	]	]	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	57	10	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	58	1	2	2	LS
work_26nhqvmztzhljeufl75hmtirqi	58	2	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	59	1	Kansu	Kansu	NNP
work_26nhqvmztzhljeufl75hmtirqi	59	2	E	E	NNP
work_26nhqvmztzhljeufl75hmtirqi	59	3	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	59	4	Gooley	Gooley	NNP
work_26nhqvmztzhljeufl75hmtirqi	59	5	T	T	NNP
work_26nhqvmztzhljeufl75hmtirqi	59	6	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	59	7	Flowers	Flowers	NNP
work_26nhqvmztzhljeufl75hmtirqi	59	8	ME	ME	NNP
work_26nhqvmztzhljeufl75hmtirqi	59	9	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	59	10	et	et	NNP
work_26nhqvmztzhljeufl75hmtirqi	59	11	al	al	NNP
work_26nhqvmztzhljeufl75hmtirqi	59	12	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	60	1	Administration	administration	NN
work_26nhqvmztzhljeufl75hmtirqi	60	2	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	60	3	cyclo-	cyclo-	NNP
work_26nhqvmztzhljeufl75hmtirqi	60	4	sporine	sporine	NNP
work_26nhqvmztzhljeufl75hmtirqi	60	5	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	60	6	24	24	CD
work_26nhqvmztzhljeufl75hmtirqi	60	7	months	month	NNS
work_26nhqvmztzhljeufl75hmtirqi	60	8	compared	compare	VBN
work_26nhqvmztzhljeufl75hmtirqi	60	9	with	with	IN
work_26nhqvmztzhljeufl75hmtirqi	60	10	6	6	CD
work_26nhqvmztzhljeufl75hmtirqi	60	11	months	month	NNS
work_26nhqvmztzhljeufl75hmtirqi	60	12	for	for	IN
work_26nhqvmztzhljeufl75hmtirqi	60	13	prevention	prevention	NN
work_26nhqvmztzhljeufl75hmtirqi	60	14	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	60	15	chronic	chronic	JJ
work_26nhqvmztzhljeufl75hmtirqi	60	16	graft	graft	NN
work_26nhqvmztzhljeufl75hmtirqi	60	17	-	-	HYPH
work_26nhqvmztzhljeufl75hmtirqi	60	18	versus	versus	IN
work_26nhqvmztzhljeufl75hmtirqi	60	19	-	-	HYPH
work_26nhqvmztzhljeufl75hmtirqi	60	20	host	host	NN
work_26nhqvmztzhljeufl75hmtirqi	60	21	disease	disease	NN
work_26nhqvmztzhljeufl75hmtirqi	60	22	:	:	:
work_26nhqvmztzhljeufl75hmtirqi	60	23	a	a	DT
work_26nhqvmztzhljeufl75hmtirqi	60	24	prospective	prospective	JJ
work_26nhqvmztzhljeufl75hmtirqi	60	25	randomized	randomized	JJ
work_26nhqvmztzhljeufl75hmtirqi	60	26	clin-	clin-	JJ
work_26nhqvmztzhljeufl75hmtirqi	60	27	ical	ical	JJ
work_26nhqvmztzhljeufl75hmtirqi	60	28	trial	trial	NN
work_26nhqvmztzhljeufl75hmtirqi	60	29	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	61	1	Blood	blood	NN
work_26nhqvmztzhljeufl75hmtirqi	61	2	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	62	1	2001;98:3868	2001;98:3868	CD
work_26nhqvmztzhljeufl75hmtirqi	62	2	-	-	SYM
work_26nhqvmztzhljeufl75hmtirqi	62	3	3870	3870	CD
work_26nhqvmztzhljeufl75hmtirqi	62	4	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	63	1	3	3	LS
work_26nhqvmztzhljeufl75hmtirqi	63	2	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	64	1	Chao	Chao	NNP
work_26nhqvmztzhljeufl75hmtirqi	64	2	NJ	NJ	NNP
work_26nhqvmztzhljeufl75hmtirqi	64	3	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	64	4	Parker	Parker	NNP
work_26nhqvmztzhljeufl75hmtirqi	64	5	PM	PM	NNP
work_26nhqvmztzhljeufl75hmtirqi	64	6	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	64	7	Niland	Niland	NNP
work_26nhqvmztzhljeufl75hmtirqi	64	8	JC	JC	NNP
work_26nhqvmztzhljeufl75hmtirqi	64	9	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	64	10	et	et	NNP
work_26nhqvmztzhljeufl75hmtirqi	64	11	al	al	NNP
work_26nhqvmztzhljeufl75hmtirqi	64	12	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	65	1	Paradoxical	paradoxical	JJ
work_26nhqvmztzhljeufl75hmtirqi	65	2	effect	effect	NN
work_26nhqvmztzhljeufl75hmtirqi	65	3	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	65	4	tha-	tha-	DT
work_26nhqvmztzhljeufl75hmtirqi	65	5	lidomide	lidomide	NN
work_26nhqvmztzhljeufl75hmtirqi	65	6	prophylaxis	prophylaxis	JJ
work_26nhqvmztzhljeufl75hmtirqi	65	7	on	on	IN
work_26nhqvmztzhljeufl75hmtirqi	65	8	chronic	chronic	JJ
work_26nhqvmztzhljeufl75hmtirqi	65	9	graft	graft	NN
work_26nhqvmztzhljeufl75hmtirqi	65	10	-	-	HYPH
work_26nhqvmztzhljeufl75hmtirqi	65	11	vs.-host	vs.-host	NN
work_26nhqvmztzhljeufl75hmtirqi	65	12	disease	disease	NN
work_26nhqvmztzhljeufl75hmtirqi	65	13	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	66	1	Biol	Biol	NNP
work_26nhqvmztzhljeufl75hmtirqi	66	2	Blood	Blood	NNP
work_26nhqvmztzhljeufl75hmtirqi	66	3	Marrow	Marrow	NNP
work_26nhqvmztzhljeufl75hmtirqi	66	4	Transplant	Transplant	NNP
work_26nhqvmztzhljeufl75hmtirqi	66	5	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	67	1	1996;2:86	1996;2:86	CD
work_26nhqvmztzhljeufl75hmtirqi	67	2	-	-	SYM
work_26nhqvmztzhljeufl75hmtirqi	67	3	92	92	CD
work_26nhqvmztzhljeufl75hmtirqi	67	4	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	68	1	4	4	LS
work_26nhqvmztzhljeufl75hmtirqi	68	2	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	69	1	Kneppers	knepper	NNS
work_26nhqvmztzhljeufl75hmtirqi	69	2	E	E	NNP
work_26nhqvmztzhljeufl75hmtirqi	69	3	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	69	4	van	van	NNP
work_26nhqvmztzhljeufl75hmtirqi	69	5	der	der	IN
work_26nhqvmztzhljeufl75hmtirqi	69	6	Holt	Holt	NNP
work_26nhqvmztzhljeufl75hmtirqi	69	7	B	B	NNP
work_26nhqvmztzhljeufl75hmtirqi	69	8	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	69	9	Kersten	Kersten	NNP
work_26nhqvmztzhljeufl75hmtirqi	69	10	MJ	MJ	NNP
work_26nhqvmztzhljeufl75hmtirqi	69	11	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	69	12	et	et	NNP
work_26nhqvmztzhljeufl75hmtirqi	69	13	al	al	NNP
work_26nhqvmztzhljeufl75hmtirqi	69	14	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	70	1	Lenalidomide	lenalidomide	JJ
work_26nhqvmztzhljeufl75hmtirqi	70	2	maintenance	maintenance	NN
work_26nhqvmztzhljeufl75hmtirqi	70	3	following	follow	VBG
work_26nhqvmztzhljeufl75hmtirqi	70	4	non	non	JJ
work_26nhqvmztzhljeufl75hmtirqi	70	5	-	-	JJ
work_26nhqvmztzhljeufl75hmtirqi	70	6	myeloablative	myeloablative	JJ
work_26nhqvmztzhljeufl75hmtirqi	70	7	allogeneic	allogeneic	NNS
work_26nhqvmztzhljeufl75hmtirqi	70	8	stem	stem	NN
work_26nhqvmztzhljeufl75hmtirqi	70	9	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	70	10	transplantation	transplantation	NN
work_26nhqvmztzhljeufl75hmtirqi	70	11	in	in	IN
work_26nhqvmztzhljeufl75hmtirqi	70	12	multiple	multiple	JJ
work_26nhqvmztzhljeufl75hmtirqi	70	13	myeloma	myeloma	NN
work_26nhqvmztzhljeufl75hmtirqi	70	14	is	be	VBZ
work_26nhqvmztzhljeufl75hmtirqi	70	15	not	not	RB
work_26nhqvmztzhljeufl75hmtirqi	70	16	feasible	feasible	JJ
work_26nhqvmztzhljeufl75hmtirqi	70	17	:	:	:
work_26nhqvmztzhljeufl75hmtirqi	70	18	results	result	NNS
work_26nhqvmztzhljeufl75hmtirqi	70	19	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	70	20	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	70	21	HOVON	HOVON	NNP
work_26nhqvmztzhljeufl75hmtirqi	70	22	76	76	CD
work_26nhqvmztzhljeufl75hmtirqi	70	23	trial	trial	NN
work_26nhqvmztzhljeufl75hmtirqi	70	24	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	71	1	Blood	blood	NN
work_26nhqvmztzhljeufl75hmtirqi	71	2	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	72	1	2011	2011	CD
work_26nhqvmztzhljeufl75hmtirqi	72	2	June	June	NNP
work_26nhqvmztzhljeufl75hmtirqi	72	3	20	20	CD
work_26nhqvmztzhljeufl75hmtirqi	72	4	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	73	1	Epub	Epub	NNS
work_26nhqvmztzhljeufl75hmtirqi	73	2	ahead	ahead	RB
work_26nhqvmztzhljeufl75hmtirqi	73	3	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	73	4	print	print	NN
work_26nhqvmztzhljeufl75hmtirqi	73	5	]	]	-RRB-
work_26nhqvmztzhljeufl75hmtirqi	73	6	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	74	1	5	5	CD
work_26nhqvmztzhljeufl75hmtirqi	74	2	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	75	1	Pidala	Pidala	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	2	J	J	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	3	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	75	4	Bloom	Bloom	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	5	GC	GC	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	6	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	75	7	Enkemann	Enkemann	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	8	S	S	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	9	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	75	10	Eschrich	Eschrich	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	11	S	S	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	12	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	75	13	Lancaster	Lancaster	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	14	J	J	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	15	,	,	,
work_26nhqvmztzhljeufl75hmtirqi	75	16	Anasetti	Anasetti	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	17	C.	C.	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	18	Biomarkers	Biomarkers	NNP
work_26nhqvmztzhljeufl75hmtirqi	75	19	to	to	TO
work_26nhqvmztzhljeufl75hmtirqi	75	20	discern	discern	VB
work_26nhqvmztzhljeufl75hmtirqi	75	21	transplantation	transplantation	NN
work_26nhqvmztzhljeufl75hmtirqi	75	22	tolerance	tolerance	NN
work_26nhqvmztzhljeufl75hmtirqi	75	23	after	after	IN
work_26nhqvmztzhljeufl75hmtirqi	75	24	allogeneic	allogeneic	IN
work_26nhqvmztzhljeufl75hmtirqi	75	25	hematopoietic	hematopoietic	JJ
work_26nhqvmztzhljeufl75hmtirqi	75	26	cell	cell	NN
work_26nhqvmztzhljeufl75hmtirqi	75	27	transplantation	transplantation	NN
work_26nhqvmztzhljeufl75hmtirqi	75	28	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	76	1	Biol	Biol	NNP
work_26nhqvmztzhljeufl75hmtirqi	76	2	Blood	Blood	NNP
work_26nhqvmztzhljeufl75hmtirqi	76	3	Marrow	Marrow	NNP
work_26nhqvmztzhljeufl75hmtirqi	76	4	Transplant	Transplant	NNP
work_26nhqvmztzhljeufl75hmtirqi	76	5	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	77	1	2010;16:729	2010;16:729	CD
work_26nhqvmztzhljeufl75hmtirqi	77	2	-	-	SYM
work_26nhqvmztzhljeufl75hmtirqi	77	3	738	738	CD
work_26nhqvmztzhljeufl75hmtirqi	77	4	.	.	.
work_26nhqvmztzhljeufl75hmtirqi	78	1	The	the	DT
work_26nhqvmztzhljeufl75hmtirqi	78	2	Doorstep	Doorstep	NNP
work_26nhqvmztzhljeufl75hmtirqi	78	3	to	to	IN
work_26nhqvmztzhljeufl75hmtirqi	78	4	the	the	DT
work_26nhqvmztzhljeufl75hmtirqi	78	5	Temple	Temple	NNP
work_26nhqvmztzhljeufl75hmtirqi	78	6	of	of	IN
work_26nhqvmztzhljeufl75hmtirqi	78	7	Wisdom	Wisdom	NNP
work_26nhqvmztzhljeufl75hmtirqi	78	8	Acknowledgments	Acknowledgments	NNPS
work_26nhqvmztzhljeufl75hmtirqi	78	9	References	References	NNPS